Chlamydia antibodies, chlamydia heat shock protein, and adverse sequelae after pelvic inflammatory disease: the PID Evaluation and Clinical Health (PEACH) Study.

@article{Ness2008ChlamydiaAC,
  title={Chlamydia antibodies, chlamydia heat shock protein, and adverse sequelae after pelvic inflammatory disease: the PID Evaluation and Clinical Health (PEACH) Study.},
  author={Roberta B. Ness and David E Soper and Holly Elizabeth Richter and Hugh Randall and Jeffrey F Peipert and Deborah Nelson and Diane Schubeck and S Gene Mcneeley and Wayne Trout and Debra C. Bass and Katherine Hutchison and Kevin E. Kip and Robert C. Brunham},
  journal={Sexually transmitted diseases},
  year={2008},
  volume={35 2},
  pages={129-35}
}
BACKGROUND Among women with pelvic inflammatory disease (PID), we assessed the associations among antibodies to Chlamydia trachomatis elementary bodies (EB), antibodies to chlamydia heat shock protein (Chsp60), rates of pregnancy, and PID recurrence. METHODS Four hundred forty-three women with clinical signs and symptoms of mild to moderate PID enrolled in the PID Evaluation and Clinical Health Study were followed for a mean of 84 months for outcomes of time-to-pregnancy and time-to-PID… CONTINUE READING